Latest Breaking News On - Johnc martin - Page 5 : vimarsana.com

In memoriam

In memoriam May 3, 2021 Dr John C Martin, former chairman and CEO of Gilead Sciences, Inc, passed away on March 30 in California at the age of 70. A true innovator, John transformed Gilead from a mid-sized player into a juggernaut in the virology space, pioneering a series of revolutionary single-pill treatments that effectively reduced HIV from a deadly pandemic to a disease that is now both preventable and controllable with highly effective antiretroviral medicines. Under his stewardship, Gilead created highly effective treatments for hepatitis B and revolutionized the treatment of the hepatitis C virus (HCV) with the launch of Sovaldi, the first oral treatment for HCV in 2013. This was followed by a series of even more effective treatments, which have reduced treatment duration to 12 weeks and cure rates to above 95 percent.

United statesJohn martinOsman khalid waheedSaeed hamidLillian louJohnc martinJohnc martin foundationGilead access programAga khan universityDepartment of medicineGilead sciences incFerozsons laboratoriesGilead sciencesVoluntary licensingPrime ministerViral hepatitis elimination

Scripps Research chemist Donna Blackmond elected to National Academy of Sciences

Donna Blackmond, Ph.D., a renowned Scripps Research professor who has expanded the world s understanding of the chemistry of life, has been elected to the National Academy of Sciences in recognition of her distinguished and continuing achievements in original research.

United statesMarcia mcnuttAbraham lincolnJohnc martinPeter schultzCarnegie mellon universityGilead sciencesAmerican academy of artsNational academy of sciencesScripps researchNational academy of engineeringChemistry at scripps researchUniversity of pittsburghGerman national academy of sciences leopoldinaNational academiesChemistry department

John C Martin, 69, Dies; Led Drugmaker in Breakthroughs

John C. Martin, 69, Dies; Led Drugmaker in Breakthroughs A chemist by training, he turned Gilead Sciences into a leading, and lucrative, innovator with single-pill treatments for H.I.V. and hepatitis C. John C. Martin in 2006 with a bottle of Truvada, a groundbreaking treatment for H.I.V. made by his company, Gilead Sciences, in the Bay Area. Credit.Paul Sakuma/Associated Press April 27, 2021, 6:43 p.m. ET John C. Martin, who became a billionaire by developing and marketing a daily single-dose pill that transformed H.I.V. into a manageable disease and who popularized another drug that cures hepatitis C, died on March 30 in Palo Alto, Calif. He was 69.

Purdue universityUnited statesPalo altoSanta clara countyFoster cityGolden gate universitySan franciscoJohn milliganBristol myers squibb sustivaJohnc martinTellis alexander martinBristol myers squibbRosemary carellaJohn charles martinInternational society for antiviral researchJohnc martin foundation

John C Martin, pioneer of single-pill HIV treatment, dies unexpectedly

John C Martin, pioneer of single-pill HIV treatment, dies unexpectedly
mv-voice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mv-voice.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesPalo altoClifford samuelLillian louLou langeJohnc martinBristol myers squibb sustivaBristol myers squibbFranklin johnsonPurdue universityGolden gate universityInstitute of human virologyAmerican chemical societyAsset management companyPalo alto police department

John C Martin, pioneer of single-pill HIV treatment, dies unexpectedly

John C Martin, pioneer of single-pill HIV treatment, dies unexpectedly
paloaltoonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from paloaltoonline.com Daily Mail and Mail on Sunday newspapers.